| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YEXCR.2012.06.004 |
| P698 | PubMed publication ID | 22698646 |
| P2093 | author name string | Claudia Lange | |
| Ludger Scheja | |||
| Bärbel Brunswig-Spickenheier | |||
| Leah Eissing | |||
| P2860 | cites work | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| Peroxisome proliferator-activated receptor subtypes differentially cooperate with other transcription factors in selective transactivation of the perilipin/PEX11 alpha gene pair | Q28304065 | ||
| Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter | Q28570239 | ||
| Mesenchymal stem cells in health and disease | Q29614296 | ||
| Adipocyte differentiation from the inside out | Q29615690 | ||
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer | Q29617271 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation | Q29619212 | ||
| Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase | Q30168654 | ||
| Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms | Q31147648 | ||
| Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta | Q33855709 | ||
| Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. | Q34737346 | ||
| Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program | Q34853025 | ||
| Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis | Q35003607 | ||
| C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway | Q35004645 | ||
| The transcriptional basis of adipocyte development | Q36152414 | ||
| Glut4 storage vesicles without Glut4: transcriptional regulation of insulin-dependent vesicular traffic | Q36700615 | ||
| A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation | Q36797244 | ||
| Immunomodulatory properties of mesenchymal stromal cells | Q36896799 | ||
| PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale | Q36961001 | ||
| PPARgamma in adipocyte differentiation and metabolism--novel insights from genome-wide studies | Q37764531 | ||
| Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism | Q39673628 | ||
| Lipocalin-type prostaglandin D(2) synthase stimulates glucose transport via enhanced GLUT4 translocation | Q39962506 | ||
| Endogenous 15-deoxy-Delta(12,14)-prostaglandin J(2) synthesized by adipocytes during maturation phase contributes to upregulation of fat storage | Q40200021 | ||
| Liver X receptor preferentially activates de novo lipogenesis in human preadipocytes | Q40349455 | ||
| Prostaglandin D(2) synthase induces apoptosis in pig kidney LLC-PK1 cells | Q40769427 | ||
| Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs | Q42551374 | ||
| Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids | Q42803031 | ||
| Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes | Q42808652 | ||
| A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c | Q42829127 | ||
| Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance | Q43687860 | ||
| Lipocalin-type prostaglandin d synthase in essential hypertension | Q43908217 | ||
| Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain | Q45127694 | ||
| Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice | Q46560412 | ||
| Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? | Q47377559 | ||
| Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats | Q48945526 | ||
| Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. | Q51018136 | ||
| Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. | Q53557183 | ||
| Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease | Q63197317 | ||
| Endogenous ApoE expression modulates adipocyte triglyceride content and turnover | Q64377381 | ||
| A Simple ELISA for Screening Ligands of Peroxisome Proliferator-activated Receptor γ | Q73255470 | ||
| Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy | Q73358706 | ||
| Tissue-engineered bone regeneration | Q74268240 | ||
| Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 | ||
| High-potential human mesenchymal stem cells | Q81429135 | ||
| Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice | Q82907264 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2284-2296 | |
| P577 | publication date | 2012-06-12 | |
| P1433 | published in | Experimental Cell Research | Q1524289 |
| P1476 | title | Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells | |
| P478 | volume | 318 |
| Q34475901 | High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells. |
| Q40224864 | Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction |
| Q46853630 | Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study |
| Q91130172 | Impact of humanised isolation and culture conditions on stemness and osteogenic potential of bone marrow derived mesenchymal stromal cells |
| Q38220508 | Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience |
| Q38165928 | Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures |
Search more.